Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.

Mutation of Bruton's tyrosine kinase (Btk) impairs B cell maturation and function and results in a clinical phenotype of X-linked agammaglobulinemia. Activation of Btk correlates with an increase in the phosphorylation of two regulatory Btk tyrosine residues. Y551 (site 1) within the Src homology type 1 (SH1) domain is transphosphorylated by the Src family tyrosine kinases. Y223 (site 2) is an autophosphorylation site within the Btk SH3 domain. Polyclonal, phosphopeptide-specific antibodies were developed to evaluate the phosphorylation of Btk sites 1 and 2. Crosslinking of the B cell antigen receptor (BCR) or the mast cell Fcepsilon receptor, or interleukin 5 receptor stimulation each induced rapid phosphorylation at Btk sites 1 and 2 in a tightly coupled manner. Btk molecules were singly and doubly tyrosine-phosphorylated. Phosphorylated Btk comprised only a small fraction (</=5%) of the total pool of Btk molecules in the BCR-activated B cells. Increased dosage of Lyn in B cells augmented BCR-induced phosphorylation at both sites. Kinetic analysis supports a sequential activation mechanism in which individual Btk molecules undergo serial transphosphorylation (site 1) then autophosphorylation (site 2), followed by successive dephosphorylation of site 1 then site 2. The phosphorylation of conserved tyrosine residues within structurally related Tec family kinases is likely to regulate their activation.

[1]  K. Isselbacher,et al.  Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  O. Silvennoinen,et al.  JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin , 1993, Cell.

[3]  P. Sigler,et al.  Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain , 1995, Cell.

[4]  Ornella Parolini,et al.  Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia , 1993, Cell.

[5]  T. Roberts,et al.  Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Stuart L. Schreiber,et al.  Structure of the Pl3K SH3 domain and analysis of the SH3 family , 1993, Cell.

[7]  Y. Wan,et al.  Activation of Tsk and Btk tyrosine kinases by G protein beta gamma subunits. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E. Querfurth,et al.  Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. , 1996, The EMBO journal.

[9]  Wei Wei Wu,et al.  CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction. , 1995, International immunology.

[10]  F. Alt,et al.  Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Desiderio,et al.  BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Kinet,et al.  Activation of BTK by a Phosphorylation Mechanism Initiated by SRC Family Kinases , 1996, Science.

[13]  D. Bentley,et al.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases , 1993, Nature.

[14]  T. Hirano,et al.  Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. , 1995, Blood.

[15]  M. Saraste,et al.  Crystal structure of the SH3 domain in human Fyn; comparison of the three‐dimensional structures of SH3 domains in tyrosine kinases and spectrin. , 1993, The EMBO journal.

[16]  D J Rawlings,et al.  Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. , 1993, Science.

[17]  H. Kawakatsu,et al.  A New Monoclonal Antibody Which Selectively Recognizes the Active Form of Src Tyrosine Kinase (*) , 1996, The Journal of Biological Chemistry.

[18]  A. Satterthwaite,et al.  Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. , 1995, Immunity.

[19]  J. Fargnoli,et al.  Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase , 1995, Molecular and cellular biology.

[20]  T. Kawakami,et al.  The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Schreiber,et al.  Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. , 1995, Science.

[22]  O. Witte,et al.  Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking , 1994, Molecular and cellular biology.

[23]  J. Cambier,et al.  Signal transduction by the B cell antigen receptor and its coreceptors. , 1994, Annual review of immunology.

[24]  D. Baltimore,et al.  Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Stern,et al.  Antiserum raised against a synthetic phosphotyrosine-containing peptide selectively recognizes p185neu/erbB-2 and the epidermal growth factor receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  O. Witte,et al.  Regulation of Btk by Src family tyrosine kinases , 1996, Molecular and cellular biology.

[27]  B. Roques,et al.  NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from Sos , 1994, Nature Structural Biology.

[28]  J. Miyazaki,et al.  Defective IL-5-receptor-mediated signaling in B cells of X-linked immunodeficient mice. , 1995, International immunology.

[29]  J. Cambier,et al.  The B-cell antigen receptor complex: structure and signal transduction. , 1994, Immunology today.

[30]  T. Watanabe,et al.  IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases , 1994, The Journal of experimental medicine.

[31]  Giulio Superti‐Furga,et al.  Structure‐function relationships in Src family and related protein tyrosine kinases , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[32]  T. Yamamoto,et al.  Association of B cell antigen receptor with protein tyrosine kinase Lyn. , 1991, Science.

[33]  T. Hunter,et al.  Vertebrate non‐receptor protein–tyrosine kinase families , 1996, Genes to cells : devoted to molecular & cellular mechanisms.

[34]  Hongtao Yu,et al.  Structural basis for the binding of proline-rich peptides to SH3 domains , 1994, Cell.

[35]  P. Coffer,et al.  Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat1 alpha. , 1995, Blood.

[36]  W. Paul,et al.  Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. , 1993, Science.

[37]  S. Schreiber,et al.  Regulatory intramolecular association in a tyrosine kinase of the Tec family , 1997, Nature.

[38]  Michael J. Eck,et al.  Three-dimensional structure of the tyrosine kinase c-Src , 1997, Nature.

[39]  A. Dvorak,et al.  Spontaneous degranulation of cultured bone-marrow-derived immature mast cells from X-linked immunodeficient (Xid) mice. , 1996, International archives of allergy and immunology.

[40]  J. Fargnoli,et al.  Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  H. Nakauchi,et al.  IL-5 receptor positive B cells, but not eosinophils, are functionally and numerically influenced in mice carrying the X-linked immune defect. , 1993, International immunology.

[42]  A. Tarakhovsky,et al.  Immunodeficiency in Protein Kinase Cβ-Deficient Mice , 1996, Science.

[43]  S. Klinken,et al.  Lyn tyrosine kinase is essential for erythropoietin‐induced differentiation of J2E erythroid cells , 1997, The EMBO journal.

[44]  T. Mosmann,et al.  Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells , 1990, The Journal of experimental medicine.

[45]  T. Pawson,et al.  SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.

[46]  K. Takatsu,et al.  A monoclonal antibody against a murine CD38 homologue delivers a signal to B cells for prolongation of survival and protection against apoptosis in vitro: unresponsiveness of X-linked immunodeficient B cells. , 1995, Immunology.

[47]  R. Hendriks,et al.  B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. , 1994, The Journal of biological chemistry.

[48]  R. Lovering,et al.  The protein defective in X‐linked agammaglobulinemia, Bruton's tyrosine kinase, shows increased autophosphorylation activity in vitro when isolated from cells in which the B cell receptor has been cross‐linked , 1995, European journal of immunology.

[49]  A. Ullrich,et al.  Structure of the N-terminal SH3 domain of GRB2 complexed with a peptide from the guanine nucleotide releasing factor Sos , 1994, Nature Structural Biology.

[50]  R. Lovering,et al.  The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase , 1995, The Journal of experimental medicine.

[51]  D J Rawlings,et al.  Regulation of Btk function by a major autophosphorylation site within the SH3 domain. , 1996, Immunity.

[52]  John Kuriyan,et al.  Crystal structure of the Src family tyrosine kinase Hck , 1997, Nature.

[53]  M. Saraste,et al.  Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X‐linked agammaglobulinaemia , 1997, The EMBO journal.

[54]  M E Greenberg,et al.  Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock. , 1993, Science.

[55]  S. Tzartos,et al.  Monoclonal antibodies as site-specific probes for the acetylcholine-receptor delta-subunit tyrosine and serine phosphorylation sites. , 1995, European journal of biochemistry.

[56]  J. Rivera,et al.  Signal transduction in the activation of mast cells and basophils. , 1995, Immunology today.

[57]  Wendell A. Lim,et al.  Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains , 1995, Nature.

[58]  S. Stafford,et al.  The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils. , 1995, Journal of immunology.